SinoGenoMax

SinoGenoMax, officially known as Beijing SinoGenoMax Research Center Co., Ltd., is a leading Chinese biotechnology company specializing in genomics, proteomics, and molecular diagnostics. Established in 1998 to support China's participation in the International Human Genome Project, the company operates the Chinese National Human Genome Center of Beijing (CHGB). It provides a comprehensive suite of services, including high-throughput DNA sequencing, bioinformatics analysis, and protein identification for academic, clinical, and industrial partners. SinoGenoMax also develops and offers clinical genetic testing products for disease risk assessment, personalized medicine, and infectious disease detection, such as targeted NGS for respiratory pathogens. The company is recognized as a "Specialized and Sophisticated" enterprise in Beijing and maintains high quality standards with ISO and CNAS certifications.